輸入代號或公司名稱後按 Enter
LFVN

Lifevantage Corp

+0.10 (+1.62%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
6.28USD11.6K成交股數78.7M市值15.7本益比(近四季)0.4股價營收比-25.2%營收年增(近四季)2026-11-03下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q426Q326Q226Q125Q325Q225Q124Q424Q324Q224Q123Q3
營收42.4M-27%43.7M-35%48.9M+4%47.6M-3%58.4M+21%67.8M+31%47.2M-8%48.9M-9%48.2M51.6M51.4M53.7M
營業成本9.3M9.2M12.7M9.7M11.1M13.2M9.5M10.0M10.2M11.1M10.2M10.6M
毛利33.0M-30%34.5M-37%36.2M-4%37.8M-3%47.3M+24%54.6M+35%37.7M-8%38.9M-10%38.1M40.6M41.2M43.1M
毛利率78.0%79.0%74.0%79.5%81.0%80.5%79.9%79.5%78.9%78.6%80.2%80.2%
研發費用300K200K200K300K400K200K300K200K200K100K200K200K
銷售管理費用13.9M13.9M15.8M14.9M17.1M18.6M14.8M14.0M16.4M20.1M18.0M17.7M
營業利益1.7M-59%1.7M-51%487K-81%2.3M-22%4.1M+110%3.4M-372%2.6M+243%2.9M+82%1.9M−1.3M749K1.6M
營業利益率3.9%3.8%1.0%4.8%6.9%5.1%5.4%5.9%4.0%-2.4%1.5%3.0%
稅後淨利1.3M-63%1.4M-47%276K-85%2.2M+65%3.5M+109%2.6M-489%1.8M+190%1.3M+28%1.7M−656K629K1.0M
淨利率3.0%3.1%0.6%4.5%5.9%3.8%3.9%2.7%3.4%-1.3%1.2%1.9%
稀釋 EPS0.10-62%0.11-42%0.02-86%0.17+70%0.26+100%0.19-480%0.14+180%0.10+25%0.13-0.050.050.08
稀釋股數12.7M12.7M12.7M12.9M13.3M13.2M12.8M13.0M13.0M12.6M13.1M12.8M

資產負債表 期末餘額

科目26Q426Q326Q226Q125Q325Q225Q124Q424Q324Q224Q123Q3
現金與約當現金14.9M12.5M10.2M13.1M22.5M21.6M14.6M16.9M17.4M17.3M18.4M19.5M
應收帳款3.0M2.4M2.3M2.4M3.2M2.1M3.0M2.9M2.1M2.3M2.5M2.4M
存貨16.2M18.4M19.0M20.6M22.2M17.5M16.9M15.1M15.2M15.0M15.7M18.5M
總資產62.1M62.1M61.2M61.6M77.2M68.5M61.5M60.3M61.3M62.7M66.6M67.1M
有息負債
總負債28.5M28.8M28.2M28.4M43.2M38.6M33.8M34.3M34.5M35.4M37.3M33.6M
股東權益33.6M33.3M33.0M33.2M34.0M29.9M27.7M26.0M26.8M27.3M29.3M33.4M
負債比45.9%46.3%46.1%46.2%56.0%56.4%54.9%56.9%56.3%56.4%56.0%50.1%
淨現金(現金 − 有息負債)

現金流量表 單季

科目26Q426Q326Q226Q125Q325Q225Q124Q424Q324Q224Q123Q3
營業現金流−2.3M−583K-112%4.8M
資本支出439K349K1.1M
自由現金流−2.7M−932K-126%3.6M
折舊攤銷610K797K918K
買回庫藏股578K0.000.001.1M1.8M1.9M1.9M795K
現金股利571K500K5.5M
自由現金流率-5.8%-2.0%7.1%

營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2026 年度 · 183M
Reportable183M100.0%-20.1%
地區2026 年度 · 183M
美國135M74.2%-24.1%
日本24.1M13.2%-4.9%
Other Foreign23.0M12.6%-6.7%
美國以外 小計47.2M25.8%-5.8%
產品/服務2026 年度 · 134M
Protandim82.0M61.4%-14.0%
Life Vantage Product Line32.3M24.2%-47.4%
Love Biome Product Line9.1M6.8%
Product And Service Other4.4M3.3%-23.3%
Phys IQ Product Line3.8M2.8%-25.5%
Petandim Product Line2.0M1.5%-7.4%
True Science Product Line 小計37.9M28.3%-22.3%
AXIO Product Line 小計15.0M11.2%-2.0%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2026183M-20.1%5.1M2.8%0.406.7M
FY2025229M+14.2%9.8M4.3%0.7510.5M
FY2024200M-6.2%2.9M1.5%0.2310.0M
FY2023213M+3.4%2.5M1.2%0.203.8M
FY2022206M-6.3%3.1M1.5%0.246.4M
FY2021220M-5.5%12.9M5.9%0.9012.5M
FY2020233M+3.1%11.5M5.0%0.7915.6M
FY2019226M7.4M3.3%0.5015.3M